Cargando…

Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

Though the pathophysiology of clinical obesity is undoubtedly multifaceted, several lines of clinical evidence implicate an important functional role for glucagon-like peptide 1 (GLP-1) signalling. Clinical studies assessing GLP-1 responses in normal weight and obese subjects suggest that weight gai...

Descripción completa

Detalles Bibliográficos
Autores principales: Anandhakrishnan, Ananthi, Korbonits, Márta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5155232/
https://www.ncbi.nlm.nih.gov/pubmed/28031776
http://dx.doi.org/10.4239/wjd.v7.i20.572

Ejemplares similares